"10.1371_journal.pone.0024586","plos one","2011-10-07T00:00:00Z","Martha Sedegah; Cindy Tamminga; Shannon McGrath; Brent House; Harini Ganeshan; Jennylynn Lejano; Esteban Abot; Glenna J Banania; Renato Sayo; Fouzia Farooq; Maria Belmonte; Nalini Manohar; Nancy O Richie; Chloe Wood; Carole A Long; David Regis; Francis T Williams; Meng Shi; Ilin Chuang; Michele Spring; Judith E Epstein; Jose Mendoza-Silveiras; Keith Limbach; Noelle B Patterson; Joseph T Bruder; Denise L Doolan; C Richter King; Lorraine Soisson; Carter Diggs; Daniel Carucci; Sheetij Dutta; Michael R Hollingdale; Christian F Ockenhouse; Thomas L Richie","U.S. Military Malaria Vaccine Program, Naval Medical Research Center, Silver Spring, Maryland, United States of America; U.S. Military Malaria Vaccine Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America; Clinical Research Management, Hinckley, Ohio, United States of America; Henry M. Jackson Foundation for the Advancement of Military Medicine, Rockville, Maryland, United States of America; Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases (NIAID)/National Institutes of Health (NIH), Rockville, Maryland, United States of America; National Naval Medical Center, Bethesda, Maryland, United States of America; Division of Medical, Audio, Visual, Library and Statistical Services, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America; Allied Technology Group Inc., Rockville, Maryland, United States of America; GenVec, Inc. Gaithersburg, Maryland, United States of America; USAID, Washington, D. C., United States of America; USMMVP, Malaria Department, NMRC, Silver Spring, Maryland, United States of America","Conceived and designed the experiments: M. Sedegah DR LS CD DC CFO TLR KL JTB CRK. Performed the experiments: M. Sedegah SM BH HG JL EA GJB RS FF MB NM NOR CW FTW. Analyzed the data: SM M. Shi MRH. Contributed reagents/materials/analysis tools: SD KL JTB CRK. Wrote the paper: M. Sedegah SM DLD MRH TLR KL JTB. Obtained regulatory approval: SM NBP TLR. Served as principal investigators and performed the clinical trial: CT DR IC. Contributed to the performance of the trial: M. Spring JEE JM-S CFO TLR. Performed ELISpot and IFA assays: HG JL EA GJB RS MB NM. Performed ELISA assays: BH NOR CW. Performed flow cytometry: SM FF. Performed the GIA: CAL.","The authors have read the journal's policy and have the following conflicts: SM NOR CW worked for Clinical Research Management; JTB CRK worked for GenVec; DLD held a Pfizer Australia Senior Research Fellowship; JTB CRK DLD DC KL are inventors listed on U.S. Patent No., U.S. Patent No. 2009-0148477 A1, and international patent application PCT/US06/33982, titled “Adenoviral Vector-based Malaria Vaccines”; JTB CRK TLR KL DLD. are inventors listed on U.S. Patent Application 12/522,335, and international patent application PCT/US08/50565 titled “Adenoviral Vector-based Malaria Vaccines”. These do not alter the authors' adherence to all PLoS ONE policies on sharing data and materials.","2011","10","Martha Sedegah","MS",34,TRUE,1,1,2,1,TRUE,TRUE,TRUE,7,"17;21;26;28;29;30;33",TRUE
